logo
#

Latest news with #MatthewGalinko

Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT
Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT

Yahoo

time5 days ago

  • Business
  • Yahoo

Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT

Semler Scientific, Inc. (NASDAQ:SMLR) is one of the . Analyst Matthew Galinko of Maxim Group maintained a Buy rating on Semler Scientific, Inc. (NASDAQ:SMLR) on August 6, retaining the price target of $95.00. A doctor in focus surrounded by colleagues in a hospital setting. The analyst told investors that Semler Scientific, Inc. (NASDAQ:SMLR) has exhibited a strong commitment to the accumulation of Bitcoin, with a goal to hold 10,000 BTC by the end of 2025 and considerably more in the following years. He added that Semler Scientific, Inc.'s (NASDAQ:SMLR) ability to raise considerable funds through share issuance further supports this accumulation strategy, suggesting a strong financial strategy. Galinko further stated that Semler Scientific, Inc. (NASDAQ:SMLR) is also expanding its medical technology offerings, especially with the formation of CardioVanta, a subsidiary focused on cardiovascular market opportunities. The expected approval of new diagnostic devices may expand the company's market reach, enhancing its revenue potential. Semler Scientific, Inc. (NASDAQ:SMLR) provides technology and software solutions to improve the clinical effectiveness of healthcare providers. The company's multi-test service platform, WellChec, conducts a comprehensive evaluation of patients for chronic disease, including strokes and heart attacks, through the use of its QuantaFlo product as well as other tests. While we acknowledge the potential of SMLR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Maxim Group Lowered the PT on Intchains Group Limited, Kept a Buy Rating
Maxim Group Lowered the PT on Intchains Group Limited, Kept a Buy Rating

Yahoo

time28-07-2025

  • Business
  • Yahoo

Maxim Group Lowered the PT on Intchains Group Limited, Kept a Buy Rating

Intchains Group Limited (NASDAQ:ICG) is one of the . On May 27, Maxim Group analyst Matthew Galinko lowered the firm's price target on Intchains Group Limited (NASDAQ:ICG) from $8 to $7.5, while maintaining a Buy rating on the stock. The analyst noted that the slight price adjustment represents some near-term challenges facing the company. He highlighted that despite the challenges, its growth potential remains strong. The company reported a significant revenue increase in Q1 2025, which was mainly driven by robust sales of its new Aleo mining machines. Galinko noted Intchains Group Limited (NASDAQ:ICG)'s strategic moves, including the launch of the Goldshell Byte mining machine. He believes that this positions the company to capitalize on emerging opportunities in digital asset mining. Although the company lowered its guidance for the first half of 2025 due to tougher competition and falling cryptocurrency prices, Galinko remains optimistic. Intchains Group Limited (NASDAQ:ICG) is a holding company that provides altcoin mining products, including mining machines that use high-performance ASIC chips designed for blockchain applications. While we acknowledge the potential of ICG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Maxim Group Maintained a Buy Rating on Unusual Machines (UMAC), Kept the PT Unchanged
Maxim Group Maintained a Buy Rating on Unusual Machines (UMAC), Kept the PT Unchanged

Yahoo

time21-07-2025

  • Business
  • Yahoo

Maxim Group Maintained a Buy Rating on Unusual Machines (UMAC), Kept the PT Unchanged

Unusual Machines, Inc. (NYSEAMERICAN:UMAC) is one of the . On June 18, Matthew Galinko, an analyst from Maxim Group, maintained a Buy rating on Unusual Machines, Inc. (NYSEAMERICAN:UMAC) with a price target of $16. Galinko noted that the company recently acquired Rotor Lab, an Australian drone motor manufacturer, which enables it to focus on domestic production of drone components. The analyst highlighted that this is important because the company aims to replace foreign competitors now restricted in the US market. An array of the consumer electronics products, including mobile phones and drones. On the other hand, Unusual Machines, Inc. (NYSEAMERICAN:UMAC) decided to cancel the agreement to acquire Aloft. Galinko believes this decision shows the company's commitment to becoming a leading domestic supplier, a strategy aligned with favorable government policies that support US-based manufacturing. Unusual Machines, Inc. (NYSEAMERICAN:UMAC) designs, manufactures, and sells small drones and essential drone components. While we acknowledge the potential of UMAC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Maxim Group Remains a Buy on Innovative Eyewear, Inc. (LUCY)
Maxim Group Remains a Buy on Innovative Eyewear, Inc. (LUCY)

Business Insider

time17-05-2025

  • Business
  • Business Insider

Maxim Group Remains a Buy on Innovative Eyewear, Inc. (LUCY)

Matthew Galinko maintained a Buy rating on Innovative Eyewear, Inc. (LUCY – Research Report) yesterday. The company's shares closed yesterday at $2.80. Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter According to TipRanks, Galinko is an analyst with an average return of -3.8% and a 38.84% success rate. Galinko covers the Technology sector, focusing on stocks such as Adeia, Unisys, and WISeKey International Holding. Currently, the analyst consensus on Innovative Eyewear, Inc. is a Moderate Buy with an average price target of $9.00.

New Buy Rating for Strategy (MSTR), the Technology Giant
New Buy Rating for Strategy (MSTR), the Technology Giant

Business Insider

time09-05-2025

  • Business
  • Business Insider

New Buy Rating for Strategy (MSTR), the Technology Giant

In a report released today, Dan Dolev from Mizuho Securities maintained a Buy rating on Strategy (MSTR – Research Report), with a price target of $563.00. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Dolev covers the Technology sector, focusing on stocks such as Robinhood Markets, Block, and Affirm Holdings. According to TipRanks, Dolev has an average return of 0.9% and a 51.33% success rate on recommended stocks. In addition to Mizuho Securities, Strategy also received a Buy from Maxim Group's Matthew Galinko in a report issued on May 5. However, on April 30, Monness reiterated a Sell rating on Strategy (NASDAQ: MSTR). Based on Strategy's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $111.07 million and a GAAP net loss of $4.23 billion. In comparison, last year the company earned a revenue of $115.25 million and had a GAAP net loss of $53.12 million Based on the recent corporate insider activity of 54 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MSTR in relation to earlier this year. Earlier this month, Jarrod Patten, a Director at MSTR sold 1,200.00 shares for a total of $461,900.00.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store